Back to Search Start Over

Effects of imatinib mesylate on cutaneous neurofibromas associated with neurofibromatosis type 1.

Authors :
Yasuda, Ken‐ichi
Nobeyama, Yoshimasa
Ishiji, Takaoki
Ota, Arihito
Asahina, Akihiko
Source :
Clinical Case Reports. Nov2020, Vol. 8 Issue 11, p2125-2128. 4p.
Publication Year :
2020

Abstract

Imatinib mesylate seemed to inhibit development of cutaneous neurofibromas (c‐NFs) and promote growth of pre‐existing c‐NFs in our neurofibromatosis type 1 case. This report potentially provides new findings in the effects of imatinib mesylate. [ABSTRACT FROM AUTHOR]

Subjects

Subjects :
*NEUROFIBROMATOSIS 1
*IMATINIB

Details

Language :
English
ISSN :
20500904
Volume :
8
Issue :
11
Database :
Academic Search Index
Journal :
Clinical Case Reports
Publication Type :
Academic Journal
Accession number :
147017767
Full Text :
https://doi.org/10.1002/ccr3.3071